AUGELLO, MATTEO
 Distribuzione geografica
Continente #
NA - Nord America 1.467
AS - Asia 1.279
EU - Europa 918
SA - Sud America 182
AF - Africa 56
OC - Oceania 9
Totale 3.911
Nazione #
US - Stati Uniti d'America 1.430
CN - Cina 480
SG - Singapore 395
IT - Italia 366
BR - Brasile 160
HK - Hong Kong 144
GB - Regno Unito 95
IN - India 81
DE - Germania 77
RU - Federazione Russa 77
NL - Olanda 76
FI - Finlandia 48
FR - Francia 46
ID - Indonesia 40
SE - Svezia 38
VN - Vietnam 32
CA - Canada 23
JP - Giappone 23
KR - Corea 23
TR - Turchia 20
AT - Austria 19
CI - Costa d'Avorio 19
IE - Irlanda 17
ES - Italia 13
ZA - Sudafrica 13
MX - Messico 12
PL - Polonia 12
AU - Australia 9
BD - Bangladesh 7
AR - Argentina 6
SA - Arabia Saudita 6
ZW - Zimbabwe 6
CH - Svizzera 5
CZ - Repubblica Ceca 5
MY - Malesia 5
EC - Ecuador 4
EG - Egitto 4
LV - Lettonia 4
NG - Nigeria 4
PH - Filippine 4
PT - Portogallo 4
BE - Belgio 3
IL - Israele 3
KE - Kenya 3
UZ - Uzbekistan 3
CL - Cile 2
CO - Colombia 2
ET - Etiopia 2
IR - Iran 2
MA - Marocco 2
NO - Norvegia 2
PE - Perù 2
PK - Pakistan 2
PY - Paraguay 2
RS - Serbia 2
UA - Ucraina 2
ZM - Zambia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
BO - Bolivia 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
GT - Guatemala 1
GY - Guiana 1
HU - Ungheria 1
IQ - Iraq 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
PA - Panama 1
RO - Romania 1
SC - Seychelles 1
UY - Uruguay 1
VE - Venezuela 1
Totale 3.911
Città #
Dallas 423
Ashburn 210
Singapore 204
Milan 164
Hefei 126
Hong Kong 116
Beijing 93
Los Angeles 74
Chicago 65
Chandler 55
Southend 44
Bengaluru 42
Jakarta 37
Santa Clara 31
Buffalo 29
Frankfurt am Main 26
Boardman 25
Council Bluffs 24
São Paulo 24
Munich 22
Helsinki 21
Salt Lake City 21
Guangzhou 20
Abidjan 19
New York 18
Rome 17
Seoul 17
Dublin 16
Moscow 16
Istanbul 15
Fairfield 14
Lappeenranta 14
Princeton 14
The Dalles 14
Elk Grove Village 13
Phoenix 13
Shanghai 13
Tampa 13
Tokyo 13
Vienna 13
Cangzhou 12
Seattle 12
Turku 12
Turin 11
Florence 10
Fremont 10
Hanoi 10
Amsterdam 9
Coventry 9
Houston 9
Montreal 9
Nuremberg 9
Paris 9
Sterling 9
Boston 8
Chennai 8
Columbus 8
London 8
Toronto 8
Warsaw 8
Cambridge 7
Ho Chi Minh City 7
Coyoacán 6
Denver 6
Genoa 6
Harare 6
Johannesburg 6
Orem 6
Rio de Janeiro 6
Fuzhou 5
Mumbai 5
Nanjing 5
Poplar 5
Riyadh 5
Roubaix 5
San Francisco 5
Stockholm 5
Sydney 5
Valencia 5
Atlanta 4
Brooklyn 4
Campobasso 4
Changsha 4
Düsseldorf 4
Haiphong 4
Joinville 4
Lauterbourg 4
Medford 4
Mexico City 4
Perugia 4
Pretoria 4
Quanzhou 4
Reston 4
Riga 4
Silver Spring 4
Wilmington 4
Woodbridge 4
Ann Arbor 3
Belo Horizonte 3
Bene Vagienna 3
Totale 2.523
Nome #
Six-month immune responses to mRNA-1273 vaccine in combination antiretroviral therapy treated late presenter people with HIV according to previous SARS-CoV-2 infection 243
Long-Term Suppressive cART Is Not Sufficient to Restore Intestinal Permeability and Gut Microbiota Compositional Changes 215
Primary HIV infection features colonic damage and neutrophil inflammation yet containment of microbial translocation 207
The importance of patients’ case-mix for the correct interpretation of the hospital fatality rate in COVID-19 disease 168
Declining mortality rate of hospitalised patients in the second wave of the COVID-19 epidemics in Italy : Risk factors and the age-specific patterns 165
Clinical Outcome and 7-Day Virological Clearance in High-Risk Patients with Mild–Moderate COVID-19 Treated with Molnupiravir, Nirmatrelvir/Ritonavir, or Remdesivir 159
Immunologic Interplay Between HIV/AIDS and COVID-19: Adding Fuel to the Flames? 154
Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023 149
Association between SARS-CoV-2 RNAemia, skewed T cell responses, inflammation, and severity in hospitalized COVID-19 people living with HIV 144
Gamma-Delta T-Cell Phenotype and Function in DAA-Treated HIV-HCV Co-Infected and HCV-Mono-Infected Subjects 143
Female gender is associated with long COVID syndrome : a prospective cohort study 142
Multi-layered deep immune profiling, SARS-CoV-2 RNAemia and inflammation in unvaccinated COVID-19 individuals with persistent symptoms 139
Persistence of High Percentage of Peripheral Activated CD8+ T Cells Predict Cytologic HPV-Related Dysplasia in cART-Treated, HIV-Positive Subjects 138
Association between SARS-CoV-2 RNAemia and dysregulated immune response in acutely ill hospitalized COVID-19 patients 135
Hallmarks of Severe COVID-19 Pathogenesis: A Pas de Deux Between Viral and Host Factors 123
Predictors of low ovarian reserve in cART-treated women living with HIV 116
Effectiveness of dolutegravir-based vs boosted darunavir-based first-line 3-drug regimens in people with HIV with advanced dimalsease: a trial emulation 110
Comparable gut mucosal breakdown and microbial translocation in severe COVID-19 with and without HIV infection 109
Effectiveness and predictors of treatment discontinuation of long-acting cabotegravir/rilpivirine in virologically suppressed people with HIV: real-life data from the Icona Cohort 108
Predicting humoral responses to primary and booster SARS-CoV-2 mRNA vaccination in people living with HIV: a machine learning approach 95
Should SARS-CoV-2 serological testing be used in the decision to deliver a COVID-19 vaccine booster? A pro-con assessment 95
A Quantitative Estimate of the Expected Shortening of the Median Isolation Period of Patients With COVID-19 After the Adoption of a Symptom-Based Strategy 95
Risk of clinical events in virologically suppressed people with HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulation 94
Gut-dependent inflammation and alterations of the intestinal microbiota in individuals with perinatal HIV exposure and different HIV serostatus 87
Renal microsporidiosis due to Encephalitozoon cuniculi in an HIV/AIDS patient with persistent fever and kidney injury 85
Failure of CD4+ T-cell recovery upon virally-effective cART : an enduring gap in the understanding of HIV+ immunological non-responders 82
Switching from intravenous to oral antibiotic therapy in the treatment of infective endocarditis: a case series and literature review of real-world data 81
SARS-CoV-2 mRNA Vaccine Response in People Living with HIV According to CD4 Count and CD4/CD8 Ratio 76
Markers of T-cell dysfunction and not inflammaging predict the waning of humoral responses to SARS-CoV-2 mRNA booster vaccination in people with HIV 74
Long-term immune responses to SARS-CoV-2 Omicron BA.4/5 mRNA booster in people living with HIV 74
Risk of COVID-19 in-hospital mortality in people living with HIV compared to general population according to age and CD4 strata: data from the Icona network 71
ORCHESTRA Delphi consensus: clinical management of SARS-CoV-2 infection in people with HIV 69
Effectiveness of first-line lamivudine/dolutegravir antiretroviral therapy in persons with HIV: real-life data from the ICONA Foundation cohort 62
Incidence, risk factors and outcomes of healthcare-associated bacterial infections in COVID-19 patients receiving respiratory support: a retrospective cohort study 35
Totale 4.042
Categoria #
all - tutte 13.015
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.015


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202160 0 0 0 0 0 0 11 7 7 20 9 6
2021/2022168 8 16 3 12 10 14 17 8 41 10 5 24
2022/2023274 12 13 14 18 22 41 19 24 33 3 42 33
2023/2024458 38 22 29 35 69 42 56 37 11 23 54 42
2024/20251.263 30 90 28 97 64 61 59 66 51 260 226 231
2025/20261.819 278 506 562 370 103 0 0 0 0 0 0 0
Totale 4.042